The worst trade deal ever for access to medicines is being signed today, but there’s still time to stop it! bit.ly/1StjIBC
President Obama is expected to push for finalization of the Trans-Pacific Partnership (TPP) in tonight’s State of the Union address. MSF is deeply concerned that unless damaging provisions are removed before negotiations are finalized, the TPP agreement could become the most harmful trade pact ever for access to medicines in developing countries. Read why and help us fight back: http://bit.ly/ZLBmEl
Damaging intellectual property rules in the U.S.-led Trans-Pacific Partnership Agreement (TPP) would give pharmaceutical companies longer monopolies over brand name drugs. Companies would be able to charge high prices for longer periods of time. And it would be much harder for generic companies to produce cheaper drugs that are vital to people’s health. We need your help:http://www.doctorswithoutborders.org/take-action/tpp/
As negotiations for the Trans-Pacific Partnership (TPP) Agreement move to Malaysia this week, Doctors Without Borders/Médecins Sans Frontières (MSF) urges negotiating countries to remove terms that could block people from accessing affordable medicines, choke off production of generic medicines, and constrain the ability of governments to pass laws in the interest of public health. Read more - http://bit.ly/15yjz3j
Countries Must Fix Critical Access to Medicines Flaws in Trans-Pacific Trade Pact
Negotiations on the Trans-Pacific Partnership (TPP)—a far-reaching trade agreement between 11 Pacific Rim countries—continue to be shrouded in secrecy, but leaked copies of the agreement reveal that the United States is demanding the most harmful package of intellectual property protections ever proposed for a trade agreement with developing countries.
These rules would make it extremely difficult for generic competitors to enter the market, keeping prices unaffordably high, with devastating public health consequences.